Shalini Sharp, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,212 shares at $141.90 ($314K) on 2024-05-17, disclosed to the SEC on 2024-05-21.
Scheduled sale ($314k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.90 | 1,106 | $157K | 50.0% |
| 2 | $141.90 | 1,106 | $157K | 50.0% |
| Total | $141.90 avg | 2,212 | $314K | 100% |
| Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |
| RARE | SELL | 2019-04-17 | $133K | — | Filing → |